参考文献
［1］Torre L A，Bray F，Siegel R L，et al.Global cancer statistics，2012［J］.CA Cancer J Clin，2015，65（2）：87-108.
［2］Chen W，Zheng R，Baade P D，et al.Cancer statistics in China，2015［J］.CA Cancer J Clin，2016，66（2）：115-132.
［3］Kim H C，Lee J H，Chung J W，et al.Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein［J］.J Vasc Interv Radiol，2013，24（2）：274-283.
［4］Le Treut Y P，Hardwigsen J，Ananian P，et al.Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature.A European case-control series［J］.J Gastrointest Surg，2006，10（6）：855-862.
［5］Kokudo T，Hasegawa K，Yamamoto S，et al.Surgical treatment of hepatocellular carcinoma associated with hepatic vein tumor thrombosis［J］.J Hepatol，2014，61（3）：583-588.
［6］Kudo M，Izumi N，Kokudo N，et al.Management of hepatocellular carcinoma in Japan：Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology（JSH）2010 updated version［J］.Dig Dis，2011，29（3）：339-364.
［7］Hashimoto T，Minagawa M，Aoki T，et al.Caval invasion by liver tumor is limited［J］.J Am Coll Surg，2008，207（3）：383-392.
［8］Florman S，Weaver M，Primeaux P，et al.Aggressive resection of hepatocellular carcinoma with right atrial involvement［J］.Am Surg，2009，75（11）：1104-1108.
［9］European Association for the Study of the Liver.EASL Clinical Practice Guidelines：management of hepatocellular carcinoma［J］.J Hepatol，2018，69（1）：182-236.
［10］Chen Z H，Wang K，Zhang X P，et al.A new classification for hepatocellular carcinoma with hepatic vein tumor thrombus［J］.Hepatobiliary Surg Nutr，2020，9（6）：717-728.
［11］Li A J，Zhou W P，Lin C，et al.Surgical treatment of hepatocellular carcinoma with inferior vena cava tumor thrombus：a new classification for surgical guidance［J］.Hepatobiliary Pancreat Dis Int，2013，12（3）：263-269.
［12］Kokudo T，Hasegawa K，Matsuyama Y，et al.Liver resection for hepatocellular carcinoma associated with hepatic vein invasion：a Japanese nationwide survey［J］.Hepatology，2017，66（2）：510-517.
［13］Chen Z H，Zhang X P，Wang K，et al.Liver resection versus transcatheter arterial chemoembolization for the treatment of patients with hepatocellular carcinoma and hepatic vein or inferior vena cava tumor thrombus：A propensity score matching analysis［J］.Hepatol Res，2019，49（4）：441-452.
［14］Komatsu S，Kido M，Asari S，et al.Particle radiotherapy，a novel external radiation therapy，versus liver resection for hepatocellular carcinoma accompanied with inferior vena cava tumor thrombus：A matched-pair analysis［J］.Surgery，2017，162（6）：1241-1249.
［15］Wang Y，Yuan L，Ge R L，et al.Survival benefit of surgical treatment for hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus：results of a retrospective cohort study［J］.Ann Surg Oncol，2013，20（3）：914-922.
［16］Wakayama K，Kamiyama T，Yokoo H，et al.Surgical management of hepatocellular carcinoma with tumor thrombi in the inferior vena cava or right atrium［J］.World J Surg Oncol，2013，11：259.
［17］Zhang X P，Liu Y C，Chen Z H，et al.Postoperative adjuvant transarterial chemoembolization improves outcomes of hepatocellular carcinoma associated with hepatic vein invasion：a propensity score matching analysis［J］.Ann Surg Oncol，2019，26（5）：1465-1473.
［18］Kasai Y，Hatano E，Seo S，et al.Proposal of selection criteria for operative resection of hepatocellular carcinoma with inferior vena cava tumor thrombus incorporating hepatic arterial infusion chemotherapy［J］.Surgery，2017，162（4）：742-751.
［19］Zhu L，Yang R，Zhu X，et al.Transcatheter arterial chemoembolization experience for advanced hepatocellular carcinoma with right atrial tumor thrombus［J］.J Cancer Res Ther，2019，15（2）：305-311.
［20］Kim Y J，Jung J，Joo J H，et al.Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion：Neces sity to subclassify Barcelona Clinic Liver Cancer stage C［J］.Radiother Oncol，2019，141（19）：95-100.(https://www.daowen.com)
［21］Koo J E，Kim J H，Lim Y S，et al.Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus［J］.Int J Radiat Oncol Biol Phys，2010，78（1）：180-187.
［22］Gao H J，Xu L，Zhang Y J，et al.Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization：report of two cases and literature review［J］.Chin J Cancer，2014，33（5）：259-264.
［23］Lee I J，Chung J W，Kim H C，et al.Extrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava：the prevalence and determinant factors［J］.J Vasc Interv Radiol，2009，20（1）：22-29.
［24］Li Y，Liu F，Yang L，et al.External-beam radiation therapy versus surgery in the treatment of hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombi［J］.Asia Pac J Clin Oncol，2019，15（6）：316-322.
［25］Zeng Z C，Fan J，Tang Z Y，et al.A comparison of treatment combinations with and without radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombus［J］.Int J Radiat Oncol Biol Phys，2005，61（2）：432-443.
［26］杨维竹，江娜，郑曲彬，等.内支架植入术联合伽玛刀治疗肝细胞癌导致下腔静脉瘤栓的疗效分析［J］.中国介入影像与治疗学，2008，5（6）：441-444.
［27］Lou J，Li Y，Liang K，et al.Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus：a multi-center analysis［J］.BMC Cancer，2019，19（1）：668.
［28］Pao T H，Hsueh W T，Chang W L，et al.Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma［J］.BMC Cancer，2019，19（1）：560.
［29］Yang Q H，Zhang W，Liu Q X，et al.TACE combined with implantation of irradiation stent versus TACE combine with bare stent for HCC complicated by IVCTT［J］.Cardiovasc Intervent Radiol，2016，39（9）：1280-1288.
［30］Yin J，Li N，Han Y，et al.Effect of antiviral treatment with nucleotide/nucleoside analogs on postoperative prognosis of hepatitis B virus-related hepatocellular carcinoma：a two-stage longitudinal clinical study［J］.J Clin Oncol，2013，31（29）：3647-3655.
［31］肝细胞癌抗病毒治疗专家组.HBV/HCV相关性肝细胞癌抗病毒治疗专家共识［J］.中华肝脏病杂志，2014，22（5）：321-326.
［32］Bruix J，Raoul J L，Sherman M，et al.Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma：subanalyses of a phase Ⅲ trial［J］.J Hepatol，2012，57（4）：821-829.
［33］Kudo M，Finn R S，Qin S，et al.Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma：a randomised phase 3 noninferiority trial［J］.Lancet，2018，391（10126）：1163-1173.
［34］Bruix J，Qin S，Merle P，et al.Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment（RESORCE）：a randomised，double-blind，placebo-controlled，phase 3 trial［J］.Lancet，2017，389（10064）：56-66.
［35］Qin S，Bai Y，Lim H Y，et al.Randomized，multicenter，open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from Asia［J］.J Clin Oncol，2013，31（28）：3501-3508.
［36］中国医师协会肝癌专业委员会.肝细胞癌合并门静脉癌栓多学科诊治中国专家共识（2018版）［J］.中国实用外科杂志，2019，39（1）：46-52.
［37］中华医学会外科学分会门静脉高压学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识（2015版）［J］.中国实用外科杂志，2015，35（10）：1086-1090.
［38］中国门静脉高压诊断与监测研究组（CHESS），中华医学会消化病学分会微创介入协作组，中国医师协会介入医师分会急诊介入专委会，等.中国肝静脉压力梯度临床应用专家共识（2018版）［J］.中华消化外科杂志，2018，17（11）：1059-1070.
（本文引自《中国实用外科杂志》2020年第40卷第1期）